- Report
- September 2026
- 185 Pages
Global
From €4378EUR$4,750USD£3,676GBP
- Report
- August 2026
- 122 Pages
Global
From €4378EUR$4,750USD£3,676GBP
- Report
- April 2026
- 115 Pages
Global
From €4378EUR$4,750USD£3,676GBP
- Clinical Trials
- July 2026
- 2247 Pages
Global
From €3180EUR$3,450USD£2,670GBP
- Clinical Trials
- January 2026
- 1464 Pages
Global
From €3180EUR$3,450USD£2,670GBP
- Report
- August 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- August 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- August 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- July 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- July 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,569GBP
€3825EUR$4,150USD£3,212GBP
- Report
- October 2026
- 50 Pages
Global
From €2443EUR$2,650USD£2,051GBP
- Report
- October 2026
- 50 Pages
Global
From €2443EUR$2,650USD£2,051GBP
- Report
- October 2026
- 50 Pages
Global
From €2443EUR$2,650USD£2,051GBP
- Report
- March 2026
- 132 Pages
Global
From €4471EUR$4,850USD£3,753GBP
- Report
- March 2026
- 209 Pages
Global
From €4563EUR$4,950USD£3,831GBP

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more